A share price of Novo Nordisk ADR [NVO] is currently trading at $79.00, down -2.45%. An important factor to consider is whether the stock is rising or falling in short-term value. The NVO shares have gain 5.63% over the last week, with a monthly amount drifted -4.04%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novo Nordisk ADR [NYSE: NVO] stock has seen the most recent analyst activity on March 13, 2025, when Kepler upgraded its rating to a Buy. Previously, Stifel downgraded its rating to Hold on March 03, 2025. On February 12, 2025, Morgan Stanley initiated with a Equal-Weight rating. Bernstein upgraded its rating to a Mkt Perform. Goldman initiated its recommendation with a Buy and recommended $156 as its price target on May 30, 2024. BMO Capital Markets started tracking with a Outperform rating for this stock on April 12, 2024, and assigned it a price target of $163. In a note dated January 23, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $120 on this stock.
Novo Nordisk ADR experienced fluctuations in its stock price throughout the past year between $73.80 and $148.15. Currently, Wall Street analysts expect the stock to reach $156 within the next 12 months. Novo Nordisk ADR [NYSE: NVO] shares were valued at $79.00 at the most recent close of the market. An investor can expect a potential return of 97.47% based on the average NVO price forecast.
Analyzing the NVO fundamentals
Trailing Twelve Months sales for Novo Nordisk ADR [NYSE:NVO] were 42.09B which represents 29.02% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at 0.44%, Pretax Profit Margin comes in at 0.44%, and Net Profit Margin reading is 0.35%. To continue investigating profitability, this company’s Return on Assets is posted at 0.22, Equity is 0.85 and Total Capital is 0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.24 points at the first support level, and at 77.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.99, and for the 2nd resistance point, it is at 80.99.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Novo Nordisk ADR [NYSE:NVO] is 0.74. On the other hand, the Quick Ratio is 0.55, and the Cash Ratio is 0.07. Considering the valuation of this stock, the price to sales ratio is 6.31, the price to book ratio is 17.61 and price to earnings (TTM) ratio is 24.07.
